Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Marcos Aurelio Fonseca Magalhaes Filho"'
Publikováno v:
Einstein (São Paulo), Vol 22 (2024)
Externí odkaz:
https://doaj.org/article/c257c6b302d9456cb231ebb6f4803780
Autor:
Marcos Aurelio Fonseca Magalhaes Filho, PEI JYE VOON, Lindsay Carlsson, Grace Silver, Aaron Richard Hansen
Publikováno v:
Journal of Clinical Oncology. 40:TPS6603-TPS6603
TPS6603 Background: Existing data demonstrate the impact of Immune checkpoint modulators (ICMs) on Health-Related Quality of Life (HRQOL), but this was from studies that used HRQOL tools developed for patients treated with chemotherapy and/or radiati
Autor:
Mirella Stival, Pedro Nazareth Aguiar, Marcos Aurelio Fonseca Magalhaes Filho, Auro Del Giglio
Publikováno v:
Journal of Clinical Oncology. 40:e13651-e13651
e13651 Background: Despite the growing popularity of teleoncology in the context of the COVID-19 pandemic, there is great concern about the quality and accuracy of clinical encounters as there is virtually no physical examination (PE) provided. Objec
Autor:
Kirsty Taylor, Jinfeng Zou, Marcos Aurelio Fonseca Magalhaes Filho, Karen Howarth, Giovanni Marsico, Samantha Terrell, Gregory Jones, Charlene Knape, Tim Forshew, Marc Oliva, Anna Spreafico, Aaron Richard Hansen, Simon McDade, Victoria M. Coyle, Mark Lawler, Elena Elimova, Scott Victor Bratman, Lillian L. Siu
Publikováno v:
Journal of Clinical Oncology. 40:6052-6052
6052 Background: Immuno-oncology agents (IO) have become standard-of-care in the treatment of R/M HNSCC, but only a subset of patients (pts) benefit. Highly sensitive quantification of plasma circulating tumor DNA (ctDNA) may permit real time assessm
Publikováno v:
Jornal Brasileiro de Pneumologia, Vol 49, Iss 6 (2023)
Externí odkaz:
https://doaj.org/article/41b90aad95084d16873888501f9911a2
Autor:
Felipe Marques da Costa, Milena Tenorio Cerezoli, Augusto Kreling Medeiros, Marcos Aurélio Fonseca Magalhães Filho, Suellen Nastri Castro
Publikováno v:
Jornal Brasileiro de Pneumologia, Vol 49, Iss 3 (2023)
Externí odkaz:
https://doaj.org/article/19c2268dc4c543a99de79651bf53068e
Autor:
Elaine Aparecida Forgiarini, Milena Tenorio Cerezoli, Augusto Kreling Medeiros, Marcos Aurélio Fonseca Magalhães Filho, Felipe Marques da Costa
Publikováno v:
Jornal Brasileiro de Pneumologia, Vol 49, Iss 2 (2023)
Externí odkaz:
https://doaj.org/article/34bc5de58ff149e28755949c5f515780
Autor:
Marcos Aurélio Fonseca Magalhães Filho, Pedro Nazareth Aguiar Jr., Milena Brachmans Mascarenhas Neves, Gilberto de Lima Lopes Jr., Auro del Giglio
Publikováno v:
Einstein (São Paulo), Vol 20 (2022)
ABSTRACT Objective Human epidermal growth factor receptor 2 (HER2) overexpression occurs in up to 30% of breast cancer cases. Ado-trastuzumab emtansine (T-DM1) is approved to treat residual HER2-positive breast cancer after neoadjuvant therapy. The a
Externí odkaz:
https://doaj.org/article/9e06eda09e8340119e5ddc732253becb
Autor:
Lilian Arruda do Rêgo Barros, Marcos Aurélio Fonseca Magalhães Filho, Rafaela de Brito Alves, Camilla Vieira de Rebouças, Cicilia Marques Rodrigues, Micaela Mazutti Viu, Vinicius de Lima Benedito, Alayne Magalhães Trindade Domingues Yamada, Auro del Giglio, Felipe José Silva Melo Cruz
Publikováno v:
Einstein (São Paulo), Vol 19 (2021)
ABSTRACT Objective To evaluate the severity of COVID-19 in cancer patients to describe clinical and epidemiological factors associated with poor outcomes (mortality and need of intensive care unit admission or mechanical ventilation). Methods Retrosp
Externí odkaz:
https://doaj.org/article/84a76ed648394b1b9c7810c05a38c087